Kerry Garman's "First, Do No Harm" Delivers a Compelling Story of Justice, Ethics, and Corporate Accountability

Bastrop, Texas, United States - Aug 25, 2026 - A timely legal thriller that follows a class action lawsuit against a pharmaceutical giant.

In his latest novel, First, Do No Harm , author Kerry Garman combines legal suspense, medical controversy, and corporate intrigue in a story that reflects some of the most pressing questions facing modern healthcare.

The novel centers on a small but determined law firm that launches a class action lawsuit against Landers Pharmaceutical after mounting evidence suggests that a popular weight-loss medication may have caused devastating health complications for patients across the country. As attorneys gather evidence and interview victims, they uncover a trail of troubling questions surrounding the drug's development, testing, and approval process.

The investigation leads to former pharmaceutical employees, medical researchers, and expert witnesses whose discoveries reveal potential misconduct hidden beneath years of corporate success. As the lawsuit gains national attention, the legal team faces mounting pressure from powerful interests determined to protect the company and its reputation.

More than a courtroom drama, First, Do No Harm examines the personal impact of large-scale corporate decisions. Patients struggling with serious illnesses become the driving force behind a legal battle that seeks answers, accountability, and justice. Their stories bring emotional depth to a novel grounded in realistic legal and pharmaceutical processes.

Garman's extensive professional experience adds authenticity to every stage of the narrative, from the complexities of class action litigation to the inner workings of pharmaceutical development and regulatory oversight. The result is a sophisticated thriller that will appeal to readers who enjoy legal fiction, medical suspense, and stories driven by ethical conflict.

With its blend of suspense, realism, and social relevance, First, Do No Harm offers a compelling exploration of what can happen when profit, science, and human lives intersect.

About the Author

Kerry Garman is an author and retired executive whose career included leadership roles across multiple industries, including pharmaceutical manufacturing. His fiction draws upon decades of professional experience to create realistic, engaging stories about business, ethics, and human resilience.

Media Contact
Company Name: Book Writing Maestros
Contact Person: Kerry Garman
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=kerry-garmans-first-do-no-harm-delivers-a-compelling-story-of-justice-ethics-and-corporate-accountability]
Phone: 15122934627
Address:208 Tributary Way
City: Bastrop
State: Texas
Country: United States
Website: https://kerrygarmanbooks.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.